Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Dermatology | Humira | Psoriasis | Skin